Norrby-Teglund A - Search Results

1

Risk Factors and Predictors of Mortality in Streptococcal Necrotizing Soft-tissue Infections: A Multicenter Prospective Study.

Bruun T, Rath E, Madsen MB, Oppegaard O, Nekludov M, Arnell P, Karlsson Y, Babbar A, Bergey F, Itzek A, Hyldegaard O, Norrby-Teglund A, Skrede S; INFECT Study Group. Bruun T, et al. Clin Infect Dis. 2021 Jan 27;72(2):293-300. doi: 10.1093/cid/ciaa027. Clin Infect Dis. 2021. PMID: 31923305 Free PMC article.

2

Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections.

Norrby-Teglund A, Pauksens K, Norgren M, Holm SE. Norrby-Teglund A, et al. Scand J Infect Dis. 1995;27(2):125-30. doi: 10.3109/00365549509018991. Scand J Infect Dis. 1995. PMID: 7660074

3

Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease.

Norrby-Teglund A, Pauksens K, Holm SE, Norgren M. Norrby-Teglund A, et al. J Infect Dis. 1994 Sep;170(3):585-91. doi: 10.1093/infdis/170.3.585. J Infect Dis. 1994. PMID: 8077715

4

Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group.

Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, O'Rourke K, Talbot J, Low DE. Kaul R, et al. Clin Infect Dis. 1999 Apr;28(4):800-7. doi: 10.1086/515199. Clin Infect Dis. 1999. PMID: 10825042

5

Evidence for superantigen involvement in severe group a streptococcal tissue infections.

Norrby-Teglund A, Thulin P, Gan BS, Kotb M, McGeer A, Andersson J, Low DE. Norrby-Teglund A, et al. J Infect Dis. 2001 Oct 1;184(7):853-60. doi: 10.1086/323443. Epub 2001 Aug 15. J Infect Dis. 2001. PMID: 11509997

6

Culture-negative severe septic shock: indications for streptococcal aetiology based on plasma antibodies and superantigenic activity.

Norrby-Teglund A, Berdal JE. Norrby-Teglund A, et al. Scand J Infect Dis. 2001;33(8):634-7. doi: 10.1080/00365540110026809. Scand J Infect Dis. 2001. PMID: 11525365

7

Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial.

Darenberg J, Ihendyane N, Sjölin J, Aufwerber E, Haidl S, Follin P, Andersson J, Norrby-Teglund A; StreptIg Study Group. Darenberg J, et al. Clin Infect Dis. 2003 Aug 1;37(3):333-40. doi: 10.1086/376630. Epub 2003 Jul 17. Clin Infect Dis. 2003. PMID: 12884156 Clinical Trial.

8

Intravenous immunoglobulin adjunctive therapy in sepsis, with special emphasis on severe invasive group A streptococcal infections.

Norrby-Teglund A, Ihendyane N, Darenberg J. Norrby-Teglund A, et al. Scand J Infect Dis. 2003;35(9):683-9. doi: 10.1080/00365540310015944. Scand J Infect Dis. 2003. PMID: 14620155 Review.

9

Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.

Darenberg J, Söderquist B, Normark BH, Norrby-Teglund A. Darenberg J, et al. Clin Infect Dis. 2004 Mar 15;38(6):836-42. doi: 10.1086/381979. Epub 2004 Mar 1. Clin Infect Dis. 2004. PMID: 14999628

10

Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach.

Norrby-Teglund A, Muller MP, Mcgeer A, Gan BS, Guru V, Bohnen J, Thulin P, Low DE. Norrby-Teglund A, et al. Scand J Infect Dis. 2005;37(3):166-72. doi: 10.1080/00365540410020866. Scand J Infect Dis. 2005. PMID: 15849047

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters